A bioassay of a water-soluble benzodiazepine against sodium thiopental

F. H. Sarnquist, William Mathers, J. Brock-Utne, B. Carr, C. Canup, C. R. Brown

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The authors performed a bioassay of midazolam maleate, an investigational, water-soluble benzodiazepine, to determine the duration of sleep after a single intravenous dose. Sodium thiopental was the standard against which the midazolam maleate was assayed. Prior to operation 60 surgical patients were randomly given one of five doses of drugs, either thiopental, 180 or 270 mg, or midazolam maleate, 6.6, 10 or 15 mg. The designated drug was infused intravenously over 20 sec in a double-blind fashion. Sleep was defined as commencing when the patients stopped counting, and ending when they could respond appropriately to verbal commands. Midazolam maleate, 10 mg (9-12 mg represents 95% confidence limits), was found to be equivalent to thiopental, 200 mg, in the duration of sleep induced. Apnea following the infusion was less frequent and of shorter duration after midazolam maleate than after thiopental. It is concluded that midazolam maleate is a satisfactory agent for the induction of anesthesia, and that it is about 20 times as potent as thiopental.

Original languageEnglish (US)
Pages (from-to)149-153
Number of pages5
JournalAnesthesiology
Volume52
Issue number2
StatePublished - 1980
Externally publishedYes

Fingerprint

Thiopental
Midazolam
Benzodiazepines
Biological Assay
Water
Sleep
Apnea
Pharmaceutical Preparations
Anesthesia

ASJC Scopus subject areas

  • Medicine(all)
  • Anesthesiology and Pain Medicine

Cite this

Sarnquist, F. H., Mathers, W., Brock-Utne, J., Carr, B., Canup, C., & Brown, C. R. (1980). A bioassay of a water-soluble benzodiazepine against sodium thiopental. Anesthesiology, 52(2), 149-153.

A bioassay of a water-soluble benzodiazepine against sodium thiopental. / Sarnquist, F. H.; Mathers, William; Brock-Utne, J.; Carr, B.; Canup, C.; Brown, C. R.

In: Anesthesiology, Vol. 52, No. 2, 1980, p. 149-153.

Research output: Contribution to journalArticle

Sarnquist, FH, Mathers, W, Brock-Utne, J, Carr, B, Canup, C & Brown, CR 1980, 'A bioassay of a water-soluble benzodiazepine against sodium thiopental', Anesthesiology, vol. 52, no. 2, pp. 149-153.
Sarnquist FH, Mathers W, Brock-Utne J, Carr B, Canup C, Brown CR. A bioassay of a water-soluble benzodiazepine against sodium thiopental. Anesthesiology. 1980;52(2):149-153.
Sarnquist, F. H. ; Mathers, William ; Brock-Utne, J. ; Carr, B. ; Canup, C. ; Brown, C. R. / A bioassay of a water-soluble benzodiazepine against sodium thiopental. In: Anesthesiology. 1980 ; Vol. 52, No. 2. pp. 149-153.
@article{07e59a9f38854944a929f6545fd7c2df,
title = "A bioassay of a water-soluble benzodiazepine against sodium thiopental",
abstract = "The authors performed a bioassay of midazolam maleate, an investigational, water-soluble benzodiazepine, to determine the duration of sleep after a single intravenous dose. Sodium thiopental was the standard against which the midazolam maleate was assayed. Prior to operation 60 surgical patients were randomly given one of five doses of drugs, either thiopental, 180 or 270 mg, or midazolam maleate, 6.6, 10 or 15 mg. The designated drug was infused intravenously over 20 sec in a double-blind fashion. Sleep was defined as commencing when the patients stopped counting, and ending when they could respond appropriately to verbal commands. Midazolam maleate, 10 mg (9-12 mg represents 95{\%} confidence limits), was found to be equivalent to thiopental, 200 mg, in the duration of sleep induced. Apnea following the infusion was less frequent and of shorter duration after midazolam maleate than after thiopental. It is concluded that midazolam maleate is a satisfactory agent for the induction of anesthesia, and that it is about 20 times as potent as thiopental.",
author = "Sarnquist, {F. H.} and William Mathers and J. Brock-Utne and B. Carr and C. Canup and Brown, {C. R.}",
year = "1980",
language = "English (US)",
volume = "52",
pages = "149--153",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - A bioassay of a water-soluble benzodiazepine against sodium thiopental

AU - Sarnquist, F. H.

AU - Mathers, William

AU - Brock-Utne, J.

AU - Carr, B.

AU - Canup, C.

AU - Brown, C. R.

PY - 1980

Y1 - 1980

N2 - The authors performed a bioassay of midazolam maleate, an investigational, water-soluble benzodiazepine, to determine the duration of sleep after a single intravenous dose. Sodium thiopental was the standard against which the midazolam maleate was assayed. Prior to operation 60 surgical patients were randomly given one of five doses of drugs, either thiopental, 180 or 270 mg, or midazolam maleate, 6.6, 10 or 15 mg. The designated drug was infused intravenously over 20 sec in a double-blind fashion. Sleep was defined as commencing when the patients stopped counting, and ending when they could respond appropriately to verbal commands. Midazolam maleate, 10 mg (9-12 mg represents 95% confidence limits), was found to be equivalent to thiopental, 200 mg, in the duration of sleep induced. Apnea following the infusion was less frequent and of shorter duration after midazolam maleate than after thiopental. It is concluded that midazolam maleate is a satisfactory agent for the induction of anesthesia, and that it is about 20 times as potent as thiopental.

AB - The authors performed a bioassay of midazolam maleate, an investigational, water-soluble benzodiazepine, to determine the duration of sleep after a single intravenous dose. Sodium thiopental was the standard against which the midazolam maleate was assayed. Prior to operation 60 surgical patients were randomly given one of five doses of drugs, either thiopental, 180 or 270 mg, or midazolam maleate, 6.6, 10 or 15 mg. The designated drug was infused intravenously over 20 sec in a double-blind fashion. Sleep was defined as commencing when the patients stopped counting, and ending when they could respond appropriately to verbal commands. Midazolam maleate, 10 mg (9-12 mg represents 95% confidence limits), was found to be equivalent to thiopental, 200 mg, in the duration of sleep induced. Apnea following the infusion was less frequent and of shorter duration after midazolam maleate than after thiopental. It is concluded that midazolam maleate is a satisfactory agent for the induction of anesthesia, and that it is about 20 times as potent as thiopental.

UR - http://www.scopus.com/inward/record.url?scp=0018890698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018890698&partnerID=8YFLogxK

M3 - Article

C2 - 7352669

AN - SCOPUS:0018890698

VL - 52

SP - 149

EP - 153

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 2

ER -